Garbe C, Blum A
Department of Dermatology, University of Tübingen, Germany.
Skin Pharmacol Appl Skin Physiol. 2001 Sep-Oct;14(5):280-90. doi: 10.1159/000056358.
Rising incidence rates of cutaneous melanoma have been observed during the last three decades. At the beginning of the 1970s 3 cases and in the 1990s 9 cases per 100,000 inhabitants and year were reported by the Saarland Cancer Registry in Germany. Other incidence studies from Germany in the 1990s even reported 10-12 cases per 100,000 inhabitants and year, which is more likely to be the representative melanoma incidence in Western Germany. In a worldwide comparison this is a medium incidence rate as compared to clearly higher incidence rates in the United States (10-20 cases per 100,000 inhabitants and year) and in Australia (40-60 cases per 100,000 inhabitants and year). In Europe the highest incidence rates have been reported from Scandinavia (about 15 cases per 100,000 inhabitants and year) and the lowest from the Mediterranean countries (about 5-7 cases per 100,000 inhabitants and year). Mortality rates likewise increased in Germany between 1970 and 1995 in males from 1.7 to 3.2 cases and in females from 1.6 to 2.0 cases per 100,000 inhabitants and year. In the 1990s, in Germany and in many other countries a leveling off of mortality rates was observed. 48,928 melanoma patients have been recorded by the Central Malignant Melanoma Registry from the German-speaking countries in the time period from 1983 to September 2000, and clinico-epidemiological analysis of cutaneous melanoma is based on this data material. While 2/3 of all melanoma patients in Germany were females in the 1970s, there is now a more balanced gender distribution with more than 45% of patients being males. Age distribution does not significantly change during the last three decades. Most melanomas are diagnosed in the age group between 50 and 60 years, 22% of all melanomas are diagnosed before the 40th year of age. A clear decrease of Breslow's tumor thickness was found from the beginning of the 1980s to the mid-1990s with the median thickness decreasing from 1.3 to 0.8 mm. Lower Breslow's tumor thickness at first diagnosis of cutaneous melanoma has only been reported from Australia. This development indicates improved early recognition of cutaneous melanoma which is presently the main factor for a more favorable prognosis.
在过去三十年中,皮肤黑色素瘤的发病率一直在上升。20世纪70年代初,德国萨尔州癌症登记处报告每10万居民每年有3例,到20世纪90年代为9例。20世纪90年代德国的其他发病率研究甚至报告每10万居民每年有10 - 12例,这更可能是德国西部黑色素瘤发病率的代表。在全球范围内比较,与美国(每10万居民每年10 - 20例)和澳大利亚(每10万居民每年40 - 60例)明显更高的发病率相比,这是一个中等发病率。在欧洲,斯堪的纳维亚半岛报告的发病率最高(每10万居民每年约15例),地中海国家最低(每10万居民每年约5 - 7例)。1970年至1995年期间,德国男性的死亡率也有所上升,从每10万居民每年1.7例升至3.2例,女性从1.6例升至2.0例。在20世纪90年代,德国和许多其他国家的死亡率趋于平稳。从1983年到2000年9月,德语国家中央恶性黑色素瘤登记处记录了48928例黑色素瘤患者,皮肤黑色素瘤的临床流行病学分析就是基于这些数据资料。20世纪70年代德国所有黑色素瘤患者中有三分之二是女性,现在性别分布更加均衡,男性患者超过45%。在过去三十年中,年龄分布没有显著变化。大多数黑色素瘤在50至60岁年龄组被诊断出来,所有黑色素瘤中有22%在40岁之前被诊断出来。从20世纪80年代初到90年代中期,发现布雷斯洛肿瘤厚度明显下降,中位数厚度从1.3毫米降至0.8毫米。只有澳大利亚报告了皮肤黑色素瘤首次诊断时较低的布雷斯洛肿瘤厚度。这一发展表明皮肤黑色素瘤的早期识别有所改善,这目前是预后更有利的主要因素。